Clinical Trials Directory

Trials / Sponsors / DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals, Inc.

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnPhase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
Actinic Keratosis
Phase 32017-03-01
CompletedMicroneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face
Actinic Keratosis
Phase 22016-03-01
CompletedMaximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
Keratosis, Actinic
Phase 22016-02-01
CompletedMaximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
Keratosis, Actinic
Phase 22014-12-01
CompletedControlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (A
Actinic Keratosis
Phase 22014-09-01
CompletedTwelve Month Follow-Up of CP0108
Actinic Keratosis
—2014-08-01
CompletedSafety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on
Actinic Keratosis
Phase 32014-05-01
CompletedShort-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)
Actinic Keratosis
Phase 22011-12-01
CompletedLevulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
Keratosis, Actinic
Phase 22011-11-01
TerminatedALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
Actinic Keratoses, Skin Neoplasms
Phase 22009-05-01
CompletedLight Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light i
Acne Vulgaris
Phase 22007-03-01